Home › Funds › Siren, L.L.C. › XENE

Siren, L.L.C. position in XENE

Xenon Pharmaceuticals Inc. · Health Care

Siren, L.L.C. reported holding 718,306 shares of XENE (Xenon Pharmaceuticals Inc.) in its Q3 2026 13F filing — a position valued at US$26.7M, representing 0.63% of its reported portfolio and ranking #41 among its reported holdings. Siren, L.L.C. has disclosed XENE holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)718.31K sh
Reported value held$26.71M
Portfolio Weight0.63%
First reportedQ3 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s XENE position evolved

Siren, L.L.C. first disclosed a stake in XENE in Q3 2024 at 743,769 shares (US$29.3M). The position peaked in Q2 2026 at 1,318,564 shares, worth US$79.6M. Across 9 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 718,306 shares valued at US$26.7M — a reduction of -600,258 shares quarter over quarter.. Notable position changes include a 62% increase in Q1 2026 (shares rose 4% over the following quarter), a 46% trim in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 743.77K $29.28M New
Q4 2024 743.77K $29.16M Hold
Q1 2025 732.76K $24.58M Reduce
Q2 2025 812.76K $25.44M Add
Q3 2025 812.76K $32.63M Hold
Q4 2025 812.76K $36.43M Hold
Q1 2026 1.32M $76.67M Add
Q2 2026 1.32M $79.59M Hold
Q3 2026 718.31K $26.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (Xenon Pharmaceuticals Inc.) is a Health Care company. 42 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has Siren, L.L.C. held XENE?

Siren, L.L.C. has disclosed XENE holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in XENE?

As of Q3 2026, Siren, L.L.C. holds 718.31K shares of XENE (Xenon Pharmaceuticals Inc.), valued at $26.71M, representing 0.63% of its reported portfolio and ranking #41.

Has Siren, L.L.C. been buying or selling XENE?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in XENE. The position peaked in Q2 2026 at 1.32M shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.